Literature DB >> 16720835

Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice.

Matt W Goschnick1, Lai-Man Lau, Janet L Wee, Yong S Liu, P Mark Hogarth, Lorraine M Robb, Michael J Hickey, Mark D Wright, Denise E Jackson.   

Abstract

We investigated the role of the hematopoietic-specific tetraspanin superfamily member, TSSC6, in platelet function using wild-type mice and TSSC6-deficient mice. TSSC6 is expressed on the surface of murine platelets and is up-regulated by thrombin stimulation, indicating an intracellular pool of TSSC6. Immunoprecipitation/Western blot studies reveal a constitutive physical association of TSSC6 with the integrin alpha(IIb)beta(3) complex under strong detergent conditions. In vivo evaluation of hemostasis by tail bleeding revealed increased bleeding time, volume of blood lost, and evidence of tail rebleeds in TSSC6 null mice, indicating unstable hemostasis. Using ex vivo techniques, we showed that TSSC6-deficient platelets exhibited impaired kinetics of clot retraction, platelet aggregation at lower doses of PAR-4, and collagen and platelet spreading on fibrinogen in the presence of normal integrin alpha(IIb)beta(3) expression. TSSC6-deficient platelets showed normal alpha granule secretion, normal "inside-out" integrin alpha(IIb)beta(3) signaling (fluorescein isothiocyanate [FITC]-fibrinogen and JON/A binding), and normal platelet adhesion on fibrinogen. Furthermore, we show that absence of platelet TSSC6 affects the secondary stability of arterial thrombi in vivo upon vascular injury. These data demonstrate that TSSC6 appears to regulate integrin alpha(IIb)beta(3) "outside-in" signaling events in platelets and is necessary for stability of arterial thrombi in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720835     DOI: 10.1182/blood-2006-02-004267

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function.

Authors:  Jenny Schröder; Renate Lüllmann-Rauch; Nina Himmerkus; Irina Pleines; Bernhard Nieswandt; Zane Orinska; Friedrich Koch-Nolte; Bernd Schröder; Markus Bleich; Paul Saftig
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

Review 2.  Tetraspanins and vascular functions.

Authors:  Feng Zhang; Jayaprakash Kotha; Lisa K Jennings; Xin A Zhang
Journal:  Cardiovasc Res       Date:  2009-02-27       Impact factor: 10.787

3.  Role for ADAP in shear flow-induced platelet mechanotransduction.

Authors:  Ana Kasirer-Friede; Zaverio M Ruggeri; Sanford J Shattil
Journal:  Blood       Date:  2009-12-07       Impact factor: 22.113

Review 4.  Integrin αIIbβ3 outside-in signaling.

Authors:  Tom N Durrant; Marion T van den Bosch; Ingeborg Hers
Journal:  Blood       Date:  2017-08-09       Impact factor: 22.113

5.  The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.

Authors:  Elizabeth J Haining; Jing Yang; Rebecca L Bailey; Kabir Khan; Richard Collier; Schickwann Tsai; Steve P Watson; Jon Frampton; Paloma Garcia; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

7.  CIB1 deficiency results in impaired thrombosis: the potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3.

Authors:  M U Naik; A Nigam; P Manrai; P Millili; K Czymmek; M Sullivan; U P Naik
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

8.  CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.

Authors:  Musaed M Alshahrani; Eunice Yang; Jana Yip; Simona S Ghanem; Simon L Abdallah; Anthony M deAngelis; Cindy J O'Malley; Fatemeh Moheimani; Sonia M Najjar; Denise E Jackson
Journal:  Blood       Date:  2014-08-01       Impact factor: 22.113

9.  Disabled-2 is required for efficient hemostasis and platelet activation by thrombin in mice.

Authors:  Hui-Ju Tsai; Chien-Ling Huang; Yao-Wen Chang; Ding-Yuan Huang; Chung-Ching Lin; Jonathan A Cooper; Ju-Chien Cheng; Ching-Ping Tseng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-11       Impact factor: 8.311

10.  RGT, a synthetic peptide corresponding to the integrin beta 3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin alpha IIb beta 3 with Src kinase.

Authors:  Xiaoyu Su; Jianqing Mi; Jinsong Yan; Panagiotis Flevaris; Yuanjing Lu; Hongchen Liu; Zheng Ruan; Xuefeng Wang; Nelly Kieffer; Saijuan Chen; Xiaoping Du; Xiaodong Xi
Journal:  Blood       Date:  2008-04-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.